Oligomerized CARD16 promotes caspase-1 assembly and IL-1β processing

FEBS Open Bio

Volumn 5, Issue , 2015, Pages 348-356

  Karasawa, Tadayoshi ^a   Kawashima, Akira ^a   Usui, Fumitake ^a   Kimura, Hiroaki ^a   Shirasuna, Koumei ^a   Inoue, Yoshiyuki ^a   Komada, Takanori ^a   Kobayashi, Motoi ^a   Mizushina, Yoshiko ^a   Sagara, Junji ^b   Takahashi, Masafumi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Caspase; Cytokine; Inflammation; Interleukin

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CASPASE RECRUITMENT DOMAIN PROTEIN 16; CASPASE RECRUITMENT DOMAIN PROTEIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; OLIGOMER; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CONFOCAL LASER MICROSCOPY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; INVESTIGATIVE PROCEDURES; MALE; NORMAL HUMAN; OLIGOMERIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STRUCTURE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84928675169     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2015.04.011     Document Type: Article

References (25)

1. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 2002, 10:417-426.
2. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
3. Masumoto J., Taniguchi S., Sagara J. Pyrin N-terminal homology domain- and caspase recruitment domain-dependent oligomerization of ASC. Biochem. Biophys. Res. Commun. 2001, 280:652-655.
4. Cerretti D.P., et al. Molecular cloning of the interleukin-1β converting enzyme. Science 1992, 256:97-100.
5. Thornberry N.A., et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992, 356:768-774.
6. Lu A., et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 2014, 156:1193-1206.
7. Mariathasan S., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
8. Martinon F., Petrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
9. Duewell P., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
10. Yajima N., et al. Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice. Circulation 2008, 117:3079-3087.
11. Kawaguchi M., et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 2011, 123:594-604.
12. Usui F., et al. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 2015, 35:127-136.
13. Komada T., et al. ASC in renal collecting duct epithelial cells contributes to inflammation and injury after unilateral ureteral obstruction. Am. J. Pathol. 2014, 184:1287-1298.
14. Larsen C.M., Faulenbach M., Vaag A., Volund A., Ehses J.A., Seifert B., Mandrup-Poulsen T., Donath M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 2007, 356:1517-1526.
15. So A., et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study. Arthritis Rheum. 2010, 62:3064-3076.
16. Humke E.W., Shriver S.K., Starovasnik M.A., Fairbrother W.J., Dixit V.M. ICEBERG: a novel inhibitor of interleukin-1β generation. Cell 2000, 103:99-111.
17. Druilhe A., Srinivasula S.M., Razmara M., Ahmad M., Alnemri E.S. Regulation of IL-1β generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ. 2001, 8:649-657.
18. Lee S.H., Stehlik C., Reed J.C. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J. Biol. Chem. 2001, 276:34495-34500.
19. Lamkanfi M., Denecker G., Kalai M., D'Hondt K., Meeus A., Declercq W., Saelens X., Vandenabeele P. INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1β generation. J. Biol. Chem. 2004, 279:51729-51738.
20. Stehlik C., Dorfleutner A. COPs and POPs: modulators of inflammasome activity. J. Immunol. 2007, 179:7993-7998.
21. Reed S.E., Staley E.M., Mayginnes J.P., Pintel D.J., Tullis G.E. Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors. J. Virol. Methods 2006, 138:85-98.
22. Masumoto J., et al. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 1999, 274:33835-33838.
23. Kersse K., Lamkanfi M., Bertrand M.J., Vanden Berghe T., Vandenabeele P. Interaction patches of procaspase-1 caspase recruitment domains (CARDs) are differently involved in procaspase-1 activation and receptor-interacting protein 2 (RIP2)-dependent nuclear factor kappaB signaling. J. Biol. Chem. 2011, 286:35874-35882.
24. Qiao Q., et al. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly. Mol. Cell 2013, 51:766-779.
25. Guiet C., Vito P. Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activation. J. Cell Biol. 2000, 148:1131-1140.